{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v3.3/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Midazolam",
            "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Midazolam-Model/v1.1/Midazolam-Model.json"
        },
        {
            "Id": "Efavirenz",
            "Path": "../../Efavirenz-Model.json",
            "BuildingBlocks": [
                {
                    "Type": "Compound",
                    "Name": "Midazolam",
                    "Project": "Midazolam"
                }
            ],
            "SimulationParameters": [
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                },
                {
                    "Project": "Midazolam",
                    "Simulation": "po 3 mg (solution)",
                    "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
                    "TargetSimulations": [
                        "Mikus 2017, Midazolam alone",
                        "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                        "Katzenmaier 2010, Midazolam alone",
                        "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
                    ]
                }
            ]
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
            {
                "Project": "Efavirenz",
                "Simulation": "Ogburn 2010, 600mg SD",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Xu 2013, 600mg SD EM",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Xu 2013, 600mg SD IM",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Xu 2013, 600mg SD PM",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Mouly 2002, 200mg MD",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Mouly 2002, 400mg MD",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Liu 2008, 400 mg PO OD",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Dooley 2012, 600mg MD EM",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Dooley 2012, 600mg MD IM",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Dooley 2012, 600mg MD PM",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Huang 2012, 600mg MD",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Garg 2013, 600mg MD",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Malvestutto 2014, 600mg PO OD",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Damle 2008, 600 mg PO OD",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Soon 2010, 600mg MD over 28 days",
                "SectionReference": "model-building"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Mikus 2017, Midazolam alone",
                "SectionReference": "fitted-interaction-with-midazolam"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                "SectionReference": "fitted-interaction-with-midazolam"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Katzenmaier 2010, Midazolam alone",
                "SectionReference": "fitted-interaction-with-midazolam"
            },
            {
                "Project": "Efavirenz",
                "Simulation": "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD",
                "SectionReference": "fitted-interaction-with-midazolam"
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Goodness of fit plot for concentration in plasma",
                "SectionReference": "diagnostics-plots",
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotTypes": [
                    "predictedVsObserved",
                    "residualsOverTime"
                ],
                "Groups": [
                    {
                        "Caption": "First dose administration",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Ogburn 2010, 600mg SD",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Ogburn 2010, 600mg SD",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Xu 2013, 600mg SD EM",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Xu 2013 - CYP2B6*1/*1 genotype - Efavirenz - PO - 600 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Xu 2013, 600mg SD IM",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Xu 2013 - CYP2B6*1/*6 genotype - Efavirenz - PO - 600 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Xu 2013, 600mg SD PM",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Xu 2013 - CYP2B6*6/*6 genotype - Efavirenz - PO - 600 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Mouly 2002, 200mg MD",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Mouly 2002 - 200 mg, Day 1 - Efavirenz - PO - 200 mg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Mouly 2002, 400mg MD",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Mouly 2002 - 400 mg, Day 1 - Efavirenz - PO - 400 mg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            }
                        ]
                    },
                    {
                        "Caption": "Multiple dose administration",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Mouly 2002, 200mg MD",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Mouly 2002 - 200 mg, Day 10 - Efavirenz - PO - 200 mg - Plasma - agg. (n=8)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Mouly 2002, 400mg MD",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Mouly 2002 - 400 mg, Day 10 - Efavirenz - PO - 400 mg - Plasma - agg. (n=8)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Liu 2008, 400 mg PO OD",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Liu 2008 - Group 1, efavirenz alone - Efavirenz - PO - 400 mg - Plasma - agg. (n=16)",
                                    "Liu 2008 - Group 2, efavirenz + placebo - Efavirenz - PO - 400 mg - Plasma - agg. (n=11)",
                                    "Liu 2008 - Group 2, efavirenz alone - Efavirenz - PO - 400 mg - Plasma - agg. (n=11)"
                                ],
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Dooley 2012, 600mg MD EM",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dooley 2012 - Extensive metabolizer - Efavirenz - PO - 600 mg - Plasma - agg. (n=34)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Dooley 2012, 600mg MD IM",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dooley 2012 - Intermediate metabolizer - Efavirenz - PO - 600 mg - Plasma - agg. (n=34)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Dooley 2012, 600mg MD PM",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dooley 2012 - Slow metabolizer - Efavirenz - PO - 600 mg - Plasma - agg. (n=34)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Huang 2012, 600mg MD",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Huang 2013 - EFV administration alone - Efavirenz - PO - 600 mg - Plasma - agg. (n=12)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Garg 2013, 600mg MD",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Garg 2013 - Efavirenz without telaprevir - Efavirenz - PO - 600 mg - Plasma - agg. (n=28)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Malvestutto 2014, 600mg PO OD",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Malvestutto 2014 - Efavirenz alone - Efavirenz - PO - 600 mg - Plasma - agg. (n=14)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Damle 2008, 600 mg PO OD",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Damle 2008 - Efavirenz alone - Efavirenz - PO - 600 mg - Plasma - agg. (n=16)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Efavirenz",
                                "Simulation": "Soon 2010, 600mg MD over 28 days",
                                "Output": "Organism|PeripheralVenousBlood|Efavirenz|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Soon 2010 - Efavirenz alone - Efavirenz - PO - 600 mg - Plasma - agg. (n=12)",
                                "Color": "#0000FF"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Efavirenz",
            "Name": "Efavirenz",
            "Type": "Compound",
            "SectionReference": "final-input-parameters"
        },
        {
            "Project": "Efavirenz",
            "Name": "Sustiva",
            "Type": "Formulation",
            "SectionReference": "final-input-parameters"
        }
    ],
    "Sections": [
        {
            "Reference": "introduction",
            "Title": "Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Reference": "methods",
            "Title": "Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Reference": "modeling-strategy",
                    "Title": "Modeling Strategy",
                    "Content": "Content/Section2.1_Modeling_Strategy.md"
                },
                {
                    "Reference": "data",
                    "Title": "Data",
                    "Content": "Content/Section2.2_Data.md"
                },
                {
                    "Reference": "model-parameters-and-assumptions",
                    "Title": "Model Parameters and Assumptions",
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md"
                }
            ]
        },
        {
            "Reference": "results-and-discussion",
            "Title": "Results and Discussion",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Reference": "final-input-parameters",
                    "Title": "Final input parameters",
                    "Content": "Content/Input_table.md"
                },
                {
                    "Reference": "diagnostics-plots",
                    "Title": "Diagnostics Plots",
                    "Content": "Content/GOF_diagnostics.md"
                },
                {
                    "Reference": "ct-profiles",
                    "Title": "Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md",
                    "Sections": [
                        {
                            "Reference": "model-building",
                            "Title": "Model Building",
                            "Content": "Content/Concentration_time_profiles_building.md"
                        },
                        {
                            "Reference": "fitted-interaction-with-midazolam",
                            "Title": "Fitted interaction with Midazolam",
                            "Content": "Content/Concentration_time_profiles_mdz_interaction.md"
                        }
                    ]
                }
            ]
        },
        {
            "Reference": "conclusion",
            "Title": "Conclusion",
            "Content": "Content/Section4_Conclusion.md"
        },
        {
            "Reference": "main-references",
            "Title": "References",
            "Content": "Content/References.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}